KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Treasury Shares (2016 - 2026)

Quest Diagnostics' Treasury Shares history spans 18 years, with the latest figure at $5.1 billion for Q1 2026.

  • On a quarterly basis, Treasury Shares rose 6.28% to $5.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $5.1 billion, a 6.28% increase, with the full-year FY2025 number at $5.2 billion, up 6.65% from a year prior.
  • Treasury Shares hit $51.0 million in Q1 2026 for Quest Diagnostics, down from $52.0 million in the prior quarter.
  • Over the last five years, Treasury Shares for DGX hit a ceiling of $52.0 million in Q4 2025 and a floor of $1.0 million in Q3 2025.
  • Historically, Treasury Shares has averaged $35.1 million across 5 years, with a median of $50.0 million in 2023.
  • The widest YoY moves for Treasury Shares: up 49.02% in 2022, down 43.41% in 2022.
  • Tracing DGX's Treasury Shares over 5 years: stood at $4.7 billion in 2022, then increased by 3.27% to $4.8 billion in 2023, then grew by 0.64% to $4.9 billion in 2024, then increased by 6.65% to $5.2 billion in 2025, then fell by 1.72% to $5.1 billion in 2026.
  • Business Quant data shows Treasury Shares for DGX at $5.1 billion in Q1 2026, $5.2 billion in Q4 2025, and $4.9 billion in Q3 2025.